Velorama

Velorama infers causal gene regulatory networks (GRNs) by integrating single-cell RNA velocity and pseudotime to quantify transcription factor (TF) dynamics during cellular differentiation.


Key Features:

  • Directed Acyclic Graph Representation: Constructs a directed acyclic graph (DAG) of single-cell differentiation dynamics using pseudotime or RNA velocity to represent branching trajectories.
  • Causal Inference in GRNs: Infers causal relationships between transcription factors (TFs) and target genes by linking dynamic expression changes to regulatory effects.
  • Speed of Transcription Factor Interactions: Estimates and quantifies the speed at which TFs influence target genes, relating regulatory function to interaction kinetics.
  • Nonlinear Trajectory Accommodation: Accommodates complex, branching differentiation trajectories without requiring cells to be ordered linearly along a pseudotemporal axis.

Scientific Applications:

  • Human corticogenesis: Applied to human corticogenesis to analyze TF dynamics during cortical development.
  • Disease linkage: Identifies slow TFs associated with gliomas and fast TFs associated with neuropsychiatric diseases.
  • Investigating differentiation and disease drivers: Uncovers causal drivers of differentiation and disease by integrating dynamic expression data into GRN analysis.

Methodology:

Constructs a DAG of single-cell differentiation dynamics from pseudotime or RNA velocity and estimates the speed of transcription factor influence on target genes to infer causal TF–target relationships.

Topics

Details

License:
MIT
Cost:
Free of charge
Tool Type:
library
Operating Systems:
Mac, Linux, Windows
Programming Languages:
Python
Added:
6/19/2024
Last Updated:
11/24/2024

Operations

Publications

Singh R, Wu AP, Mudide A, Berger B. Causal gene regulatory analysis with RNA velocity reveals an interplay between slow and fast transcription factors. Cell Systems. 2024;15(5):462-474.e5. doi:10.1016/j.cels.2024.04.005. PMID:38754366. PMCID:PMC12204218.

PMID: 38754366
Funding: - National Institutes of Health: R35GM141861